
Cancer Genetics (Vyant Bio)
Cancer Genetics is laboratory that develops and commercializes proprietary genomic tests and services to empower cancer treatment.
Market cap
$1.2m
Enterprise value
($7m)
Share price
$0.26 VYNT
Recent deals
Authorizing premium user...